Tumor angiogenesis: the pivotal role of vascular endothelial growth factor

World Journal of Urology

Volumn 14, Issue 3, 1996, Pages 166-174

  Marme D ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; GROWTH FACTOR RECEPTOR; LYMPHOKINE; PROTEIN TYROSINE KINASE; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR;

ANIMAL; BLOOD VESSEL; GENETICS; HUMAN; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; STRUCTURE ACTIVITY RELATION; VASCULARIZATION;

ANIMALS; BLOOD VESSELS; ENDOTHELIAL GROWTH FACTORS; HUMANS; LYMPHOKINES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; STRUCTURE-ACTIVITY RELATIONSHIP; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0029679536     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (92)

1. Auerbach W, Auerbach R (1994) Angiogenesis inhibition: a review. Pharmacol Ther 63:265-31 l
2. Barleon B, Weich HA, Manne D (1994) Differential regulation of the two VEGF receptor genes fit-1 and kdr by cytokines and growth factors. J Cell Biochem [SupplJ ISA:323
3. Berkman RA, Merrill MJ, Reinhold WC. Monacci WT, Saxena A, Clark WC, Robertson JT, Ali IU, Oldfield EH (1993) Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 91 :153-159
4. Bicknell R (1994) Vascular targeting and the inhibition of angiogenesis. Ann Oncol 5 [Suppl]:S45-S50
5. Brogi E. Wu T, Namiki A, Isner JM (1994) Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90:649-652
6. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF, Senger DR (1993) Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder. Am J Pathol 143: 12551262
7. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR, Dvorak HF (1993) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 53:4727-4735
8. Brown LF, Berse B, Jackman RW, Tognazzi K, Guidi AJ, Dvorak HF, Senger DR, Connolly JL, Schnitt SJ (1995) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 26:86-91
9. Claffey KP, Senger DR, Spiegelman BM (1995) Structural requirements for dimerization, glycosylation, secretion, and biological function of VPF/VEGF. Biochim Biophys Acta 1246: 1-9
10. Cullinan-Bove K, Koos RD (1993) Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogeninduced increases in uterine capillary permeability and growth. Endocrinology 133:829-837
11. Czubayko F, Smith RV, Chung HC, Wellstein A (1994) Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors. J Biol Chem 269:28243-28248
12. Dameron KM, Volpert OV, Tainsky MA, Bouck N (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265: 1582-1584
13. De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT (1992) The fms-like tyrosine kinase, a receptor for vascular endothelia) growth factor. Science 255:989-991
14. Dickinson AJ, Fox SB, Persad RA, Hollyer J, Sibley ON A, Harris AL (1994) Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. BrJUrol 74:762-766
15. Dolecki GJ, Connolly DT (1991) Effects of a variety of cytokines and inducing agents on vascular permeability factor mRNA levels in U937 cells. Biochem Biophys Res Commun 180:572-578
16. Dvorak HF, Sioussat TM, Brown LF, Berse B, Nagy JA, Sotrel A, Manseau EJ, Van De Water L, Senger DR (1991) Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: Concentration in tumor blood vessels. J Exp Med 174: 1275-1278
17. Ferrara N, Henzel WJ (1989) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851-859
18. Ferrara N, Houck K, Jakeman L, Leung DW (1992) Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13:18-32
19. Fiebich BL, Jäger B, Schöllmann C, Weindel K, Wilting J, Kochs G, Marmé D, Hug H, Weich HA (1993) Synthesis and assembly of functionally active human vascular endothelial growth factor homodimers in insect cells. Eur J Biochem 211 : 19-26
20. Finkenzeller G, Marmé D, Weich HA, Hug H (1992) Plateletderived growth factor-induced transcription of the vascular endothelial growth factor gene is mediated by protein kinase C. Cancer Res 52:4821-4823
21. Finkenzeller G. Technau A, Marmé D (1995) Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor. Biochem Biophys Res Commun 208:432-439
22. Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267: 10931-10934
23. Folkman J, Watson K, Ingber D, Hanahan D (1989) Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58-61
24. Furukawa T, Yoshimura A, Sumizawa T, Haraguchi M, Akiyama S-I (1992) Angiogenic factor. Nature 356:668
25. Furusato M, Wakui S, Sasaki H, Ito K, Ushigome S (1994) Tumour angiogenesis in latent prostatic carcinoma. Br J Cancer 70:1244-1246
26. Goldman CK, Kirn J, Wong W-L, King V, Brock T, Gillespie GY (1993) Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiform pathophysiology. Mol Biol Cell 4: 121-133
27. Good DJ. Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, Bouck NP (1990) A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 87:6624-6628
28. Grischke EM, Kaufmann M, Eberlein-Gonska M, Mattfeldt T, Sohn C, Basten G (1994) Angiogenesis as a diagnostic factor in primary breast cancer: microvessel quantitation by stereological methods and correlation with color Doppler sonography. Onkologie 17:35-42
29. Grugel S. Finkenzeller G. Weindel K, Barleon B, Marmé D (1995) Both v-Ha-ras and v-raf stimulate expression of the vascular endothelial growth factor. J Biol Chem (in press)
30. Harada S, Nagy JA, Sullivan KA, Thomas KA, Endo N, Rodan GA, Rodan SB (1994) Induction of vascular endothelial growth factor expression by prostaglandin E2 and E! in osteoblasts. J Clin Invest 93:2490-2496
31. Hauser S, Weich HA (1993) A heparin-binding form of placenta growth factor (P1GF-2) is expressed in human umbilical vein endothelial cells and in placentas. Growth Factors 9: 259-268
32. Hori A, Sasada R, Matsutani E, Naito K, Sakura Y, Fujita T, Kozai Y (1991) Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res 51:6180
33. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW (1991) The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5:1806-1814
34. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N (1992) Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267:26031-26037
35. lizuka M, Yamauchi M, Ando K. Hori N, Furusawa Y, Itsukaichi H, Fukutsu K, Moriya H (1994) Quantitative RT-PCR assay detecting the transcriptional induction of vascular endothelial growth factor under hypoxia. Biochem Biophys Res Commun 205: 1474-1480
36. Jellinek D, Green LS, Bell C, Janjic N (1994) Inhibition of receptor binding by high-affinity RNA ligands to vascular endothelial growth factor. Biochemistry 33:10450-10456
37. Kandel J, Bossy-Wetzel E, Radvanyi F, Klagsbrun M, Folkman J, Hanahan D (1991) Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66:1095-1104
38. Keck PJ, Hause SD, Krivi G, Sanzo K, Warren H, Feder J, Connolly DT (1989) Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246:1309-1312
39. Kendall RL, Thomas KA (1993) Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 90:10705-10709
40. Kieser A, Weich HA, Brandner G, Marmé D, Kölch W (1994) Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9:963-969
41. Kirn KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362:841-844
42. Kondo S, Asano M, Suzuki H (1993) Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody. Biochem Biophys Res Commun 194:1234-1241
43. Kondo S, Asano M, Matsuo K, Ohmori I, Suzuki H (1994) Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim Biophys Acta 1221:211-214
44. Kondo S, Matsumoto T, Yokoyama Y, Ohmori I, Suzuki H (1995) The shortest isoform of human vascular endothelial growth factor/vascular permeability factor (VEGF/VPF12i) produced by Saccharomyces cerevisiae promotes both angiogenesis and vascular permeability. Biochim Biophys Acta 1243:195-202
45. Leek RD, Harris AL, Lewis CE (1994) Cytokine networks in solid human tumors: regulation of angiogenesis. J Leukocyte Biol 56:423-435
46. Maxwell M, Naber SP, Wolfe HJ, Hedley-Whyte ET, Galanopoulos T, Neville-Golden J, Antoniades HN (1991) Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. Cancer Res 51 : 1345-1351
47. Millauer B, Wizigmann-Voos S, Schnüren H, Martinez R, M011er NPH, Risau W, Ullrich A (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835846
48. Millauer B, Shawver KL, Plate KH, Risau W, Ullrich A (1994) Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367:576-579
49. Minchenko A, Bauer T, Salceda S, Caro J (1994) Hypoxie stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest 71:374-379
50. Moghaddam A, Zhang H-T, Fan T-PD, Hu D-E, Lees VC, Turley H, Fox SB, Gatter KC, Harris AL, Bicknell R (1995) Thymidine phosphorylase is angiogenic and promotes tumor growth. PNAS (in press)
51. Morris PB, Hida T, Blackshear PJ, Klintworth GK, Swain JL (1988) Tumor-promoting phorbol esters induce angiogenesis in vivo. Cell Physiol 23:C318-C322
52. Moses MA, Langer R (1991) Inhibitors of angiogenesis. Biotechnology 9:630-634
53. Nabel EG, Yang Z-Y, Plautz G, Forough R, Zhan X, Haudenschild CC, Maciag T, Nabel GJ (1993) Recombinant fibroblast growth factor-1 promotes intimai hyperplasia and angiogenesis in arteries in vivo. Nature 362:844-846
54. Nicosia RF, Nicosia SV, Smith M (1994) Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am J Pathol 145: 1023-1029
55. Oikawa T, Shimamura M, Ashino H (1992) Inhibition of angiogenesis by staurosporine. a potent protein kinase inhibitor. J Antibiot 45: 1 155-1160
56. Oison TA, Mohanraj D, Carson LF, Ramakrishnan S (1994) Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res 54:276-280
57. O'Reilly MS, Holmgren L, Shing Y, Chen C. Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH. Folkman J. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of métastases by a Lewis lung carcinoma. Cell 79-315-328
58. Park JE, Chen H, Winer J, Houck K, Ferrara N (1994) Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 269:25646-25654
59. Pepper MA, Montesano R (1990) Proteolytic balance and capillary morphogenesis. Cell Differ Dev 32:319-331
60. Pepper MS, Ferrara N, Orci L, Montesano R (1991) Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 181:902-906
61. Pepper MS, Ferrara N, Orci L, Montesano R (1992) Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 189:824-831
62. Peters KG, De Vries C, Williams LT (1993) Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 90:89158919
63. Plate KH, Breier G, Weich HA, Risau W (1992) Vascular endothelial growth is a potential tumour angiogenesis factor in vivo. Nature 359:845-847
64. Plate KH, Breier G, Millauer B, Ullrich A, Risau W (1993) Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 53:5822-5827
65. Plate KH, Breier G, Risau W (1994) Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol 4: 207-218
66. Plouet J, Schilling J, Gospodarowicz D (1989) Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT20 cells. EMBO J 8:3801-3807
67. Risau W, Drexler H, Mironov V, Smits A, Siegbahn A, Funa K, Heldin CH (1992) Platelet-derived growth factor is angiogenic in vivo. Growth Factors 7:261-266
68. Rosenthal R, Megyesi JF, Henzel WJ, Ferrara N, Folkman J (1990) Conditioned medium from mouse sarcoma 180 cells contains vascular endothelial growth factor. Growth Factors 4: 53-59
69. Senger D, Perruzzi CA, Feder J, Dvorak HF (1986) A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46:5269-5275
70. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime M, Sato M (1990) Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (fit) closely related to the/ms family. Oncogene 5:519-524
71. Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845
72. Sidransky D, Mikkelsen T, Schwechheimer K. Rosenblum ML, Cavanee W, Vogelstein B (1992) Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355:846-847
73. Stavri GT, Hung Y, Zachary 1C, Breier G, Baskerville PA, Ylä-Herttuala S, Risau W, Martin JF, Erusalimsky JD (1995) Hypoxia and platelet-derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells. FEBS Lett 358:311-315
74. Strugar J, Rothbart D, Harrington W, Criscuolo GR (1994) Vascular permeability factor in brain métastases: correlation with vasogenic brain edema and tumor angiogenesis. J Neurosurg 81:560-566
75. Takahashi A, Sasaki H, Kirn SJ, Tobisu K, Kakizoe T, Tsukamoto T, Kumamoto Y, Sugimura T, Terada M (1994) Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res 54: 4233-4237
76. Takahashi JA. Mori H, Fukumoto M. Igarashi K. Jaye M, Oda Y. Kikuchi H, Hatanaka M (1990) Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues. Proc Nail Acad Sci US A 87:5710-5714
77. Terano H, Shibata T, Otsuka T (1993) Angiogenesis inhibitors of microbial origin. Drugs Future 18:239-247
78. Terman Bl, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL. Shows TB (1991) Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6:519-524
79. Terman BI, Dougher-Vermazen M. Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Bohlen P (1992) Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 187:1579-1586
80. Unemori EN, Ferrari N, Bauer EA, Amento EP (1992) Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 153:557562
81. Van Meir EG, Poverini PJ, Chazin VR, Su Huang HJ, Tribolet N de, Cavenee WK (1994) Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nat Genet 8: 171-176
82. Wakui S, Furusato M, Sasaki H, Akiyama A, Kinoshito 1, Asano K, Tokuda T, Aizawa S, Ushigome S ( 1992) Tumor angiogenesis in prostatic carcinoma with and without bone métastases: a morphometric study. J Pathol 168:257-262
83. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CR (1994) Different signal transduction properties of KDR and Fit-1, two receptors for vascular endothelial growth factor. J Biol Chem 43:26988-26995
84. Weidner N (1993) Tumor angiogenesis: review of current applications in tumor prognostication. Semin Diagn Pathol 10: 302-313
85. Weidner N, Folkman J, Pozza F, Bevilacqua P. Allred EN, Moore DH, Meli S, Gasparini G (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in earlystage breast carcinoma. J Natl Cancer Inst 84:1875-1887
86. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J (1993) Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143:401-409
87. Weindel K, Moringlane JR, Marmé D, Weich HA (1994) Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis? Neurosurgery 35:439-449
88. Wilting J, Christ B, Weich HA (1992) The effects of growth factors on the day 13 chorioallantoic membrane (CAM): a study of VEGFI65 and PDGF-BB. Anat Embryol 186:251-257
89. Wilting J, Christ B, Bokeloh M, Weich HA (1993) In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane. Cell Tissue Res 274:163-172
90. Yeo TK, Senger DR, Dvorak HF, Fréter L, Yeo KT (1991) Glycosylation is essential for efficient secretion but not for permeability-enhancing activity of vascular permeability factor (vascular endothelial growth factor). Biochem Biophys Res Commun 179: 1568-1575
91. Yeo KT, Sioussat TM, Faix JD, Senger DR, Yeo TK (1992) Development of time-resolved immunofluorometric assay of vascular permeability factor. Clin Chem 38:71-75
92. Yeo KT, Wang HH, Nagy JA, Sioussat TM, Ledbetter SR, Hoogewerf AJ, Zhou Y, Masse EM, Senger DR, Dvorak HF, Yeo TK (1993) Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res 53:2912-2918